Search results
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the...
CNBC· 1 day agoIf cleared by the Food and Drug Administration, the company plans to launch Zepbound for so-called...
Better Than Ozempic? Doctors Say These Medications Are Better for Weight Loss Than the Popular...
Woman's World via Yahoo News· 5 days agoIn terms of insurance, Dr. Laster says these medications are generally difficult to get coverage for...
How Did Kelly Clarkson Lose Weight? Here's Everything You Need to Know About Her Journey
Parade· 5 days agoHow Did Kelly Clarkson Lose Weight? Ozempic has been a hot topic across the U.S. over the last few...
Eli Lilly seeks FDA’s OK to expand Zepbound’s uses to include sleep apnea
Market Watch· 1 day agoThe antiobesity medication sharply reduced the restriction or blocking of airflow in patients with ...
How Long Can You Sustain Weight Loss on Wegovy? New Research Might Have the Answer
Health via Yahoo News· 5 days agoNew research shows that people who take Wegovy may keep the weight off for for four years and that...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 2 days agoThe decision now goes to the full FDA. Eli Lilly stock broke out last month after unveiling positive...
Ozempic to treat arthritis? Why doctors say obesity drugs could cure a host of chronic illnesses
NY Post via Yahoo News· 1 day ago“You get the weight loss, and you’ve treated the high blood pressure, the fatty liver, the diabetes,...
Tirzepatide Significantly Reduces Sleep Disruptions
Medscape· 18 hours agoThe diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound forobesity) was so effective at reducing sleep disruptions in...
Children with high BMIs should not use obesity medications like WeGovy, US doctors warn
INSIDER via Yahoo News· 3 days agoHowever, not all health professionals agree with the AAP...doctors and public health experts from...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 1 day agoThe FDA is expected to give its decision later this year. Donanemab will be the second drug on the...